ranolazine has been researched along with Eulenburg Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, WD; Barohn, RJ; Cannon, SC; Fontaine, B; Griggs, RC; Hanna, MG; LoRusso, S; Matthews, E; Meola, G; Sansone, VA; Statland, JM; Stunnenberg, BC; Trivedi, JR; van Engelen, BGM; Vicart, S | 1 |
| Agriesti, J; Bartlett, A; David Arnold, W; Freimer, M; Hawash, AA; Kissel, JT; Kline, D; Lorusso, S; Rich, MM | 1 |
1 review(s) available for ranolazine and Eulenburg Disease
| Article | Year |
|---|---|
Guidelines on clinical presentation and management of nondystrophic myotonias.
Topics: Acetazolamide; Age of Onset; Carbonic Anhydrase Inhibitors; Chloride Channels; Electrodiagnosis; Electromyography; Fatigue; Genetic Testing; Humans; Lamotrigine; Mexiletine; Muscle Weakness; Muscle, Skeletal; Myalgia; Myotonia Congenita; Myotonic Disorders; NAV1.4 Voltage-Gated Sodium Channel; Practice Guidelines as Topic; Ranolazine; Sodium Channel Blockers; Voltage-Gated Sodium Channel Blockers | 2020 |
1 other study(ies) available for ranolazine and Eulenburg Disease
| Article | Year |
|---|---|
Open-label trial of ranolazine for the treatment of paramyotonia congenita.
Topics: Adult; Electromyography; Female; Hand Strength; Humans; Male; Middle Aged; Muscle Weakness; Myotonic Disorders; Pain; Ranolazine; Severity of Illness Index; Sodium Channel Blockers; Stiff-Person Syndrome | 2019 |